Fwd: Women's Health Alert

[Guest guest]

Note: forwarded message attached.

WOMEN'S HEALTH ALERT

September 26, 2005

This update is brought to you by Women's Health Weekly, a leading research newsletter for biotech and pharmaceutical professionals. For more information, go to Women's Health Weekly.

ALTERATIONS IN BRAIN SEROTONIN ACTIVITY MAY BE ASSOCIATED WITH ANOREXIA NERVOSA

Women who have had a certain type of anorexia nervosa show an alteration of the activity of a chemical in their brain that is widely associated with anxiety and other affective disorders more than one year after recovery, according to a study in the September issue of rchives of General Psychiatry one of the JAMA/Archives journals.

Anorexia nervosa, a disorder characterized by the relentless pursuit of thinness and obsessive fear of being fat, has two subtypes, a group that restricts their eating (restricting-type AN) and a group that alternates restrictive eating with bulimic symptoms such as episodes of purging and/or binge eating (bulimia-type AN), according to background information in the article.

Save on NewsRx Timed Passes

Got a short-term project for which you need a full time database of quality clinical information? NewsRx Timed Passes let you access our database of more than 240,000 articles for a day, a week, a month or up to six months at a fraction of our site license costs. You set your limits and control your costs. You get the convenience of a site license without the long-term commitment or cost. Go to Timed Access to see how.

Previous evidence has suggested that alterations in the activity of serotonin (a brain chemical involved in communication between nerve cells) may contribute to the appetite alteration in anorexia nervosa as well as playing a role in anxious, obsessional behaviors and extremes of impulse control.

Ursula F. Bailer, MD, of the University of Pittsburgh School of Medicine, Pittsburgh, and colleagues compared the activity of serotonin in women who had recovered from each of the two types of anorexia nervosa and a control group of healthy women using positron emission tomography (PET). The researchers injected a molecule that can bind to a serotonin receptor in much the same way that serotonin does into specific areas of the women's brains and used PET scans to measure the extent of the molecule-receptor binding. This molecule-receptor binding served as a marker for alterations of serotonin neuronal activity.

Thirteen women recovered from restricting-type AN, 12 women with bulimia-type AN and 18 healthy control women were included in the study.

Save a bundle!

Need a quick and inexpensive way to view the most recent research in your field? NewsRx Bundled let's you buy 10, 25, 50 articles at discounts that range from 20% to 50% off our single article price of $3 each. Need more? You size it. Set the number of articles you want and save up to 50% over our single article costs. Go to NewsRx Bundled and we'll show you how.

The researchers report increased binding of this marker molecule in several brain regions in women who had recovered from bulimia-type AN but not restricting-type AN. Only the women who had recovered restricting-type AN showed any correlation between core eating disorder symptoms and binding potential. In these women receptor binding was correlated with a measure of anxiety called harm avoidance.

"In summary, this study lends further credibility to the possibility that women with AN have a persistent disturbance of 5-HT [serotonin] neuronal systems that may be related to increased anxiety," the authors conclude.

"While it cannot be certain whether 5-HT alterations are a 'scar' following cessation of low weight and malnutrition, the fact that premorbid anxiety disorders occur in AN supports the possibility that altered 5-HT pathway function could predate the onset of AN and persist after recovery. There are no proven treatments for AN, and this illness has the highest mortality of any psychiatric disorder. These data offer the promise of a new understanding of the pathogenesis of AN and new drug and psychological treatment targets."

Custom Reports at Discount Prices

Tired of prepackaged reports that just don't meet your needs? Build your own custom report from the NewsRx database. You control the size and the cost, while enjoying discounts that range from 20% to 50% off our regular article price. Go to Custom reports for more information.

You are receiving NewsRx Women's Health Alert per your request entered at our website, www.NewsRx.com. Please feel free to share this email with interested colleagues, but do not forward unless requested. If you are receiving this email in error, you may unsubscribe from all alerts.

NewsRx does not and will not share your email address with anyone. It is used solely for the purposes of delivering to you requested free Alerts. Privacy Policy and User Agreement

Copyright © 2005 NewsRx Inc. . Designated trademarks and brands are the property of their respective owners. NewsRx is headquartered at 2900 Paces Ferry Rd, Bldg D, Floor 2, Atlanta, GA, 30339. Phone: 770-507-7777 or 800-726-4550; Fax: 770-435-6800; Email: CustomerService@....